The University of Kentucky Markey Cancer Center has treated the first patient in US with a new immunotherapy for lung cancer. UK Markey Cancer Center becomes the first site in the country…
Tag: Lung Cancer Drugs
Sevabertinib Receive Accelerated Approval by FDA for Non-Squamous NSCLC
Lung cancer is one of the deadly disease responsible for many deaths all around the world. US Food and Drug Administration (FDA) has granted accelerated approval to Sevabertinib (Hyrnuo Bayer HealthCare Pharmaceuticals…
Lurbinectedin Combination gets FDA Approval for Extensive-Stage SCLC
The U.S. Food and Drug Administration (FDA) has approved lurbinectedin (Zepzelca) in combination with atezolizumab or and hyaluronidase-tqjs for adults with extensive-stage small cell lung cancer (ES-SCLC) without disease progression after frontline…
FDA Approves Hernexeos for HER2-Mutant Advanced Lung Cancer
For the first time, FDA has given approval of an oral treatment of patients with unresectable or metastatic non-squamous non-small cell lung cancer whose tumors have human epidermal growth factor receptor 2…
High-Dose Aumoltertinib for Untreated EGFR- Variant NSCLC
Aumoltertinib is a third-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and has achieved potent efficacy for advanced EGFR-mutated non-small cell lung cancer patients. Phase 2 non-randomized clinical trial was conducted at…
Study: Tagrisso As Backbone Therapy for Lung Cancer
Lung cancer remains the leading cause of cancer-related deaths worldwide. It is broadly classified into small cell lung cancer and non-small cell lung cancer. The latter accounts for about 80% of the…
Metformin Appears To Fight Lung Cancer But Only In Overweight Patients
Metformin is a common drug prescribed for patients with Type 2 patients to lower their blood sugar. It is a FDA approved drug since 1995 and is used by about 20 million…
FDA Approves New Drug for Lung Cancer
Lung cancer is one of the leading causes behind cancer related deaths. Various studies and research works are going on to help lung cancer patients to get cure from this disease. Time-to-time,…